SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CYTO
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rod who wrote (7484)4/5/1999 9:15:00 PM
From: ge  Read Replies (1) of 8116
 
From the perspective of what he considers genetic engineering, Cyto has not done anything that is in the realm of anything more than 5 year old technology . He could not get enough info on what Axcell was doing but he did not find a flood of new patient applications, so he suspects that they are repackaging GDL technology ( 5 years old or better). He explained differing processes of genetic linking and gave me some companies that use and continue to improve on these processes but again said that these guys (CYTO) have been on vacation for many years and now without R&D money he did not see how they would keep up. His advice was to look at the patients and when they were filed and see when the pace dropped off. He explained that when a company is doing high end work, they will be filing a good number of patients. He also suggested that you look at the patient streams of other Bios to see just how many is enough.
If Quad sales do not do 100M a year where will the money come from? More stock sales? Do they need an eraser (reverse split) in order to raise more money? He does think that the company has value and he thinks that the price is low ( his guess), especially if there is a sale of the company as a whole. I am not buying till I get some answers ( contracts and partnerships) on what the value of Axcell will be.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News